PHILCLONESTYL 250

INSTRUCTIONS FOR USE:

POSOLOGY AND METHOD OF ADMINISTRATION

Posology

In general, for adults, 250 mg of chlorphenesin carbamic acid ester is orally administered 3 times a day. The dose may be adjusted according to the patient's age and symptoms.

Method of administration

For oral.

Special populations

Elderly

In general, elderly people have decreased physiological function, so be careful about reducing the dose.

Paediatric population

The safety of this drug has not been established, 125 mg chlorphenesin carbamate blister not been administered to children in clinical studies.

Other

When using the drug for a long time, it is recommended to carry out clinical tests (blood tests, urine tests, liver function tests, etc.).

CONTRAINDICATIONS

Do not administer to the following patients:

Patients with a history of hypersensitivity to this drug and similar compounds (methocarbamol, etc.)

Patients with hepatic disorder

SPECIAL WARNINGS AND PRECAUTIONS FOR USE

Caution should be exercised when using the drug for the following subjects:

Patients with a history of liver damage (see Contraindications)

Patients with impaired kidney function

FERTILITY, PREGNANCY AND LACTATION

Pregnancy

Administer to pregnant women or women who may be pregnant only if the therapeutic benefit outweighs the risk. (The safety of administration during pregnancy has not been established).

Lactation

It is recommended not to administer to lactating women.

EFFECTS ON ABILITY TO DRIVE AND USE MACHINES

Patients receiving this drug should not be engaged in dangerous machine operations such as driving a car, as drowness, decreased attention, concentration and reflexive motor ability may occur.

SHELF-LIFE

36 months from the manufacturing date and 3 months after opening.

STORAGE

Store in a dry place, below 30°C, protect from light.